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Suspected 
Brazilian Purpuric 
Fever, Brazilian 
Amazon Region
To the Editor: Brazilian pur-
puric fever (BPF), a Haemophilus 
aegyptius–caused febrile hemorrhagic 
illness of children that begins with 
conjunctivitis and has a case-fatality 
rate of 40%–90% (1,2), was ﬁ  rst rec-
ognized during a 1984 outbreak. Be-
fore June 2007, 69 cases were reported 
worldwide; 65 were from Brazil (1–3). 
To our knowledge, the disease had not 
been reported in the Amazon region 
until this investigation, which was 
precipitated by the report of 5 cases 
of a compatible syndrome in Anajás, 
Pará State, Brazil, in August 2007.
To determine whether recent re-
ports of BPF were accurate, we re-
viewed medical records of the hospi-
tal in Anajás. We identiﬁ  ed cases by 
using the following deﬁ  nition: fever 
>38.5ºC , abdominal pain, vomiting, 
purpura, and antecedent conjuncti-
vitis during July 1–September 30, 
2007, in a child 3 months–10 years 
of age; absence of signs or symptoms 
of meningitis in those children; and 
laboratory exclusion of meningococ-
cal infection. In addition, we searched 
retrospectively and prospectively for 
conjunctivitis among pupils of the 
elementary schools of Anajás dur-
ing July–September 2007. We found 
7 children with illnesses that met our 
case deﬁ  nition.
From 2 children with nonfatal ill-
ness, we collected blood, serum, con-
junctival swabs, and cerebrospinal ﬂ  uid 
(CSF). All specimens were submitted 
for bacterial culture in half agar choco-
late without bacitracin; serum and CSF 
were also subjected to real-time PCR 
for detection of Neisseria meningitides, 
Streptococcus pneumoniae, and Hae-
mophilus inﬂ  uenzae serotypes a, b, c, 
and d and to conventional PCR for the 
ompP2 gene of H. inﬂ  uenzae. All serum 
samples were also tested by hemag-
glutination inhibition for Flavivirus, 
Oropouche, Catu, Caraparu, Tacaiuma, 
Mayaro, Mucambo, western equine en-
cephalitis, eastern equine encephalitis, 
Guaroa, Maguari, Ilhéus, Rocio, and St. 
Louis encephalitis; by immunoglobulin 
M antibody-capture ELISA for dengue 
and yellow fever; and, when reactive 
for dengue, by reverse transcription–
PCR for dengue types 1, 2, 3, and 4.
Because of the remoteness of 
the outbreak site, samples for bacte-
rial culture were collected on locally 
available blood agar enriched with 
rabbit serum without antimicrobial 
drug–selective agents, rather than on 
the recommended chocolate agar en-
riched with horse serum and bacitra-
cin (1). Samples were transported over 
several days by open boat at ambient 
temperature (≈35 ºC) in improvised 
containers without an incubator. Se-
rum and CSF samples were thawed 
and refrozen repeatedly for removal of 
aliquots before testing. Microbiologic 
and virologic testing was conducted at 
the Pará State Health Laboratory and 
Evandro Chagas Institute. Serum and 
CSF samples were tested by PCR at 
Adolfo Lutz Institute.
We identiﬁ  ed 7 case-patients (me-
dian age 4 years, range 2–8 years): 6 
from review of charts at the local hos-
pital and 1 from active search in the 
rural community. Onset of illness was 
August 1 for the ﬁ  rst case-patient and 
August 31 for the last. Five (71%) did 
not receive antimicrobial drugs and 
died within 24 hours after fever onset; 
2 were treated with amoxicillin within 
24 hours after fever onset and survived 
(Table).
Laboratory tests showed leuko-
penia on the day of hospital admis-
sion (Table). All case-patients had 
antecedent conjunctivitis. All except 
the ﬁ  rst case-patient had had physical 
contact with a previous case-patient 
through school or family; 5 were re-
lated (siblings or cousins). The period 
from exposure to onset of fever was 
8–21 days.
Of 1,598 elementary school pu-
pils investigated for conjunctivitis, 111 
(7%) reported symptoms of conjunc-
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Table. Characteristics of 7 case-patients with suspected Brazilian purpuric fever, Amazon region, Brazil, August 2007* 
Case-
patient no.
Sex/age,
y
Date of 
conjunctivitis 
onset
Date admitted 
to hospital
Hospitalization,
d
Antimicrobial
drug
treatment
Date of 
death
Type of sample(s) 
collected WBC/mL
1 M/2 Aug 1 Aug 5 <1 No Aug 5 NC NT
2 F/3 Aug 10 Aug 13 <1 No Aug 14 Blood 3,700
3 M/3 Aug 14 Unknown Unknown  No Aug 21 NC NT
4 M/6 Jul 19  Aug 22  <1 No Aug 23  Blood 2,300
5† M/8 Unknown Sep  3 7 Yes – CSF,  conjunctival 
swab
9,060
6 F/4 Aug 23 Aug 26 <1 No Aug 26 CSF, blood‡ 2,000
7 F/4 Aug 31 Sept 3 12 Yes – Oropharyngeal 
and conjunctival 
swabs, CSF, 
blood, serum
4,800
*Case-patients 5 and 7 underwent testing for dengue and yellow fever by immunoglobulin M antibody-capture ELISA, for dengue by reverse transcription–
PCR, and for Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae serotypes a, b, c, and d and conventional PCR for 
detecting the ompP2 gene. All tests were negative. WBC, white blood cells; NC, not collected; NT, not tested; CSF, cerebrospinal fluid. 
†Sample collected 20 days after admission. 
‡Non-standard collection, transport, storage, or processing. THE AMAZON REGION  LETTERS
tivitis during July–September 2007. 
Reported treatment included home 
remedies and a nonprescription, local-
ly available, cream containing a sulfa 
drug. Review of municipal hospital 
records during June 1–September 30, 
2007, identiﬁ  ed no additional cases of 
conjunctivitis. After the last case-pa-
tient died, 17 other persons were iden-
tiﬁ  ed with purulent conjunctivitis: 4 at 
the municipal hospital and 13 during 
active case-ﬁ  nding in schools and the 
community. All were treated with oral 
amoxicillin and chloramphenicol optic 
solution, and 76 contacts were treated 
prophylactically with oral rifampin. 
No further suspected BPF cases were 
detected. Test results for acute arbovi-
rus infection and PCR were negative 
for all patients (Table).
This outbreak of highly fatal ill-
ness is clinically compatible with BPF. 
Compatible features included young 
age, antecedent purulent conjunctivitis, 
signs and symptoms (i.e., antecedent 
conjunctivitis, fever 39.5Cº–41.0Cº, 
abdominal pain, nausea, vomiting, 
petechiae or ecchymoses), and high 
case-fatality rate. Epstein-Barr infec-
tion has reportedly produced simi-
lar symptoms (4) but with an illness 
lasting >7 days in contrast to the <24 
hours for our case-patients.
We did not detect H. aegyptius in 
peripheral blood by culture or in se-
rum or CSF by PCR in the 2 surviv-
ing children and in contacts of case-
patients. One reason could be the 
remoteness of the investigation site, 
which resulted in improper sample 
collection, storage, and processing 
in the ﬁ   eld before samples reached 
reference laboratories. Hemaggluti-
nation tests for arboviruses have low 
speciﬁ  city. Therefore, another known 
or novel pathogen could have caused 
these cases.
Timely treatment with antimicro-
bial drugs for patients with suspected 
disease, prophylaxis of contacts, and 
treatment of children with conjunctivi-
tis resulted in no additional cases. In-
tensive surveillance for febrile illness 
preceded by conjunctivitis, immediate 
treatment, contact prophylaxis, and 
appropriate prompt laboratory testing 
are essential for continued control of 
BPF in this region.
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Hepatitis C Virus 
in Blood Donors, 
Brazil
To the Editor: The Fundação 
de Hematologia e Hemoterapia do 
Amazonas is a public health service 
in Manaus, Brazil, that is responsible 
for serologic screening the serum of 
all blood donations in the region. In 
the state of Amazon, 9.0% of donated 
blood is discarded on the basis of se-
rologic  ﬁ   ndings; discarding because 
of hepatitis C virus (HCV) antibod-
ies declined from 1.25% in 1995 to 
0.32% in 2007. The aim of this study 
was to characterize the serologic and 
molecular proﬁ   le of HCV-antibody–
positive blood donors from the Funda-
ção de Hematologia e Hemoterapia do 
Amazonas. 
For the study, 154 donors were 
selected from a routine database of 
voluntary blood donors who had do-
nated from September 2005 through 
April 2007 (82,851 donations). Fresh 
plasma samples were sent to the labo-
ratory in Manaus through the usual 
transportation systems for regular do-
nations; i.e., samples from 27 cities 
are transported by air for ≈2 hours, 
and samples from 21 localities are 
transported by boat or road, all under 
refrigerated conditions.
An in-house standardized nested-
PCR was used to detect HCV RNA (1). 
Genotype assignment was based on 
type-speciﬁ  c motifs on the sequenced 
amplicons delimited by primers HC11/
HC18 from the 5′ untranslated region 
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